Company / Gross Margin
Silence Therapeutics plc Gross Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
99.4%
FY2025
5-year range
37.8% / 99.4%
FY2024-FY2025
Trend
+162.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
99.4% in FY2025.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin increased 162.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -22.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 99.4% | +162.7% |
| FY2024 | 37.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026